Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: Analysis of the Recently Reported Findings From the European and North American SABINA Datasets

J Allergy Clin Immunol Pract. 2022 Sep;10(9):2310-2311. doi: 10.1016/j.jaip.2022.06.012.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Asthma* / epidemiology
  • Humans
  • North America / epidemiology

Substances

  • Anti-Asthmatic Agents